U.S. Pharmaceuticals & Biotech Nano Cap Stocks

biote

Market Cap: US$49.8m

Operates in practice-building business within the hormone optimization space.

Grace Therapeutics

Market Cap: US$45.4m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

MDxHealth

Market Cap: US$41.5m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

BioXcel Therapeutics

Market Cap: US$36.7m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Dyadic International

Market Cap: US$28.2m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

Jasper Therapeutics

Market Cap: US$26.2m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.

Earth Science Tech

Market Cap: US$25.9m

Together with its subsidies, focuses on health and wellness industry.

TherapeuticsMD

Market Cap: US$24.0m

Operates as a pharmaceutical royalty company in the United States and internationally.

Cellectar Biosciences

Market Cap: US$20.8m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Biofrontera

Market Cap: US$16.6m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Bio Essence

Market Cap: US$13.5m

Engages in manufacturing and distributing health supplement products.

PDS Biotechnology

Market Cap: US$12.9m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

Pharma-Bio Serv

Market Cap: US$12.4m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Traws Pharma

Market Cap: US$8.7m

A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.

CordovaCann

Market Cap: US$4.4m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

International Stem Cell

Market Cap: US$2.8m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Emmaus Life Sciences

Market Cap: US$807.2k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Ayurcann Holdings

Market Cap: US$58.4k

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.